BOULDER, Colo., May 5, 2016 /PRNewswire/ -- Array BioPharma
Inc. (Nasdaq: ARRY) today announced that its Chief Executive
Officer, Ron Squarer, will present
at the Bank of America Merrill Lynch Healthcare Conference in Las
Vegas. The public is welcome to participate in the
conferences through a webcast on the Array BioPharma
website.
|
Event:
Bank of America Merrill Lynch Healthcare Conference
|
Date:
Tuesday, May 10, 2016
|
Time:
3:00 p.m. PDT
|
Location:
Encore at the Wynn, Las Vegas, NV
|
Webcast:
investor.arraybiopharma.com
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on
the discovery, development and commercialization of targeted small
molecule drugs to treat patients afflicted with cancer. Five
registration studies are currently advancing related to three
cancer drugs. These programs include binimetinib (MEK162),
encorafenib (LGX818) and selumetinib (AstraZeneca). For more
information on Array, please go to www.arraybiopharma.com.
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
Logo -
http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-bank-of-america-merrill-lynch-healthcare-conference-300264159.html
SOURCE Array BioPharma Inc.